|Articles|March 1, 2017
- BioPharm International-03-01-2017
- Volume 30
- Issue 3
BioPharm International, March 2017 Issue (PDF)
Click the title above to open the BioPharm International March 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Automating Bioprocessesalmost 9 years ago
Biosimilar Names Prove Difficult to Definealmost 9 years ago
Strategizing a Shortcut to Marketalmost 9 years ago
Covering Global Regulations in a Quality Systemalmost 9 years ago
Will Pharma Manufacturing Move Back to the US?almost 9 years ago
Serialization Hits the Home Stretchalmost 9 years ago
Harnessing Advances in Informatics to Ensure Data Integrityalmost 9 years ago
Being Thorough When Transferring TechnologyNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5
